{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:57:39Z","timestamp":1790143059385,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The effect of a water-soluble formulation of tylvalosin (Aivlosin\u00ae 625\u2009mg\/g granules) on disease caused by porcine reproductive and respiratory syndrome virus (PRRSV) and<jats:italic>Mycoplasma hyopneumoniae<\/jats:italic>(<jats:italic>Mhyop<\/jats:italic>) was investigated in two animal studies<jats:italic>.<\/jats:italic>In a PRRSV challenge model in pregnant sows (<jats:italic>n<\/jats:italic>\u2009=\u200918), six sows received water medicated at target dose of 5\u2009mg tylvalosin\/kg body weight\/day from 3\u2009days prior to challenge until the end of gestation. Six sows were left untreated, with a third group remaining untreated and unchallenged. Sows were challenged with PRRSV-2 at approximately 85\u2009days of gestation. Cytokines, viremia, viral shedding, sow reproductive parameters and piglet performance to weaning were evaluated. In a dual infection study (<jats:italic>n<\/jats:italic>\u2009=\u200916), piglets were challenged with<jats:italic>Mhyop<\/jats:italic>on days 0, 1 and 2, and with PRRSV-1 on day 14 and euthanized on day 24. From day 10 to 20, eight piglets received water medicated at target dose of 20\u2009mg tylvalosin\/kg body weight\/day and eight piglets were left untreated. Cytokines, viremia, bacteriology and lung lesions were evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the PRRSV challenge study in pregnant sows, tylvalosin significantly reduced the levels of serum IL-8 (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), IL-12 (<jats:italic>P<\/jats:italic>\u2009=\u20090.032), TNF\u03b1 (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and GM-CSF (<jats:italic>P<\/jats:italic>\u2009=\u20090.001). IL-8 (<jats:italic>P<\/jats:italic>\u2009=\u20090.100) tended to be lower in uterus of tylvalosin sows. All piglets from tylvalosin sows surviving to weaning were PRRSV negative in faecal swabs at weaning compared to 33.3% PRRSV positive piglets from untreated sows (<jats:italic>P<\/jats:italic>\u2009=\u20090.08).<\/jats:p><jats:p>In the dual challenge study in piglet, tylvalosin reduced serum IL1\u03b2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-1\u03b1, IL-13, IL-17A, IL-18, GM-CSF, TGF\u03b21, TNF\u03b1, CCL3L1, MIG, PEPCAM-1 (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and increased serum IFN\u03b1, IL-1ra and MIP-1b (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). In the lungs, tylvalosin reduced IL-8, IL-10 and IL-12 compared to untreated pigs (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and tended to reduce TNF\u03b1 (<jats:italic>P<\/jats:italic>\u2009=\u20090.082). Lung lavage samples from all tylvalosin treated piglets were negative for<jats:italic>Mhyop<\/jats:italic>(0\u2009cfu\/mL) compared to the untreated piglets which had mean<jats:italic>Mhyop<\/jats:italic>counts of 2.68\u2009\u00d7\u200910<jats:sup>4<\/jats:sup>\u2009cfu\/mL (<jats:italic>P\u00a0=<\/jats:italic>\u00a00.023).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Overall, tylvalosin reduced both local and systemic proinflammatory cytokines after challenge with respiratory pathogens in sows and in piglets. Tylvalosin was effective in reducing<jats:italic>Mhyop<\/jats:italic>recovery from the lungs and may reduce virus shedding in piglets following transplacental PRRSV infection in sows.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12917-023-03571-x","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T09:12:42Z","timestamp":1675242762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effects of a water-soluble formulation of tylvalosin on disease caused by porcine reproductive and respiratory syndrome virus alone in sows or in combination with Mycoplasma hyopneumoniae in piglets"],"prefix":"10.1186","volume":"19","author":[{"given":"Alfonso Lopez","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica L.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Huether","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Reddick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Tait-Burkard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"O\u2019Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirosh","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Buterbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafid A.","family":"Benchaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"issue":"Suppl 1","key":"3571_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/tbed.12677","volume":"65","author":"D Maes","year":"2018","unstructured":"Maes D, Sibila M, Kuhnert P, Segal\u00e9s J, Haesebrouck F, Pieters M. Update on Mycoplasma hyopneumoniae infections in pigs: knowledge gaps for improved disease control. Transbound Emerg Dis. 2018;65(Suppl 1):110\u201324.","journal-title":"Transbound Emerg Dis"},{"issue":"4","key":"3571_CR2","first-page":"213","volume":"65","author":"L Stipkovits","year":"2001","unstructured":"Stipkovits L, Miller D, Glavits R, Fodor L, Burch D. Treatment of pigs experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida, and Actinobacillus pleuropneumoniae with various antibiotics. Can J Vet Res. 2001;65(4):213\u201322.","journal-title":"Can J Vet Res"},{"key":"3571_CR3","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/9781119350927.ch56","volume-title":"Diseases of swine","author":"MG Pieters","year":"2019","unstructured":"Pieters MG, Maes D. Mycoplasmosis. In: Zimmerman JJ, Karriker LA, Ramirez A, Schwartz KJ, Stevenson GW, Zhang J, editors. Diseases of swine. 11th ed. Hoboken: Wiley Blackwell; 2019. p. 863\u201383.","edition":"11"},{"issue":"1","key":"3571_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13567-016-0391-4","volume":"47","author":"E Pileri","year":"2016","unstructured":"Pileri E, Mateu E. Review on the transmission porcine reproductive and respiratory syndrome virus between pigs and farms and impact on vaccination. Vet Res. 2016;47(1):108.","journal-title":"Vet Res"},{"issue":"2","key":"3571_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1051\/vetres:2000113","volume":"31","author":"K van Reeth","year":"2000","unstructured":"van Reeth K, Nauwynck H. Proinflammatory cytokines and viral respiratory disease in pigs. Vet Res. 2000;31(2):187\u2013213.","journal-title":"Vet Res"},{"key":"3571_CR6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/9781119350927.ch41","volume-title":"Diseases of swine","author":"J Zimmerman","year":"2019","unstructured":"Zimmerman J, Dee S, Holtkamp D, Murtaugh M, Stadejek T, Stevenson G, et al. Porcine reproductive and respiratory syndrome viruses (porcine Arteriviruses). In: Zimmerman JJ, Karriker LA, Ramirez A, Schwartz KJ, Stevenson GW, Zhang J, editors. Diseases of swine. 11th ed. Hoboken: Wiley Blackwell; 2019. p. 685\u201308.","edition":"11"},{"issue":"5","key":"3571_CR7","first-page":"901","volume":"11","author":"R Thanawongnuwech","year":"2004","unstructured":"Thanawongnuwech R, Thacker B, Halbur P, Thacker E. Increased production of proinflammatory cytokines following infection with porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae. Clin Diagn Lab Immunol. 2004;11(5):901\u20138.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"3571_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jcpa.2009.07.004","volume":"142","author":"J G\u00f3mez-Laguna","year":"2010","unstructured":"G\u00f3mez-Laguna J, Salguero F, Barranco I, Pallar\u00e9s F, Rodr\u00edguez-G\u00f3mez I, Bernab\u00e9 A, et al. Cytokine expression by macrophages in the lung of pigs infected with the porcine reproductive and respiratory syndrome virus. J Comp Pathol. 2010;142(1):51\u201360.","journal-title":"J Comp Pathol"},{"issue":"1","key":"3571_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1128\/MMBR.05015-11","volume":"76","author":"JR Tisoncik","year":"2012","unstructured":"Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiol Mol Biol Rev. 2012;76(1):16\u201332.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"2","key":"3571_CR10","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1016\/j.ijid.2012.06.006","volume":"17","author":"J Bordon","year":"2013","unstructured":"Bordon J, Aliberti S, Fernandez-Botran R, Uriarte S, Rane M, Duvvuri P, et al. Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. Int J Infect Dis. 2013;17(2):e76\u201383.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"3571_CR11","first-page":"156","volume":"292","author":"A Ianaro","year":"2000","unstructured":"Ianaro A, Ialenti A, Maffia P, Sautebin L, Rombola L, Carnuccio R, et al. Anti-inflammatory activity of macrolide antibiotics. J Pharmacol Exp Ther. 2000;292(1):156\u201363.","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"3571_CR12","doi-asserted-by":"publisher","first-page":"e0200474","DOI":"10.1371\/journal.pone.0200474","volume":"13","author":"A Al-Darraji","year":"2018","unstructured":"Al-Darraji A, Haydar D, Chelvarajan L, Tripathi H, Levitan B, Gao E, et al. Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: potential therapeutic targets in ischemic heart disease. PLoS One. 2018;13(7):e0200474.","journal-title":"PLoS One"},{"issue":"1","key":"3571_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1365-2796.2012.02554.x","volume":"272","author":"S Meijvis","year":"2012","unstructured":"Meijvis S, van de Garde E, Rijkers G, Bos W. Treatment with anti-inflammatory drugs in community-acquired pneumonia. J Intern Med. 2012;272(1):25\u201335.","journal-title":"J Intern Med"},{"key":"3571_CR14","first-page":"42","volume":"61","author":"AD Stuart","year":"2008","unstructured":"Stuart AD, Brown TDK, Mockett APA. Tylvalosin, a macrolide antibiotic inhibits the in-vitro replication of European and American porcine reproductive and respiratory syndrome virus (PRRS) viruses. Pig J. 2008;61:42\u20138.","journal-title":"Pig J"},{"key":"3571_CR15","doi-asserted-by":"publisher","first-page":"204020662096171","DOI":"10.1177\/2040206620961712","volume":"28","author":"D Poddighe","year":"2020","unstructured":"Poddighe D, Aljofan M. Clinical evidences on the antiviral properties of macrolide antibiotics in the COVID-19 era and beyond. Antivir Chem Chemother. 2020;28:2040206620961712.","journal-title":"Antivir Chem Chemother"},{"key":"3571_CR16","unstructured":"CVMP. European public assessment report (EPAR) for Aivlosin [Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/veterinary\/EPAR\/aivlosin."},{"issue":"1","key":"3571_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40813-020-00177-9","volume":"6","author":"A Lopez Rodriguez","year":"2020","unstructured":"Lopez Rodriguez A, Berge AC, Ramage C, Saltzman R, Domangue RJ, Gnozzio MJ, et al. Evaluation of the clinical efficacy of a water soluble formulation of tylvalosin in the control of enzootic pneumonia associated with Mycoplasma hyopneumoniae and Pasteurella multocida in pigs. Porcine Health Manag. 2020;6(1):39.","journal-title":"Porcine Health Manag."},{"key":"3571_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fvets.2018.00057","volume":"5","author":"R Moges","year":"2018","unstructured":"Moges R, De Lamache DD, Sajedy S, Renaux BS, Hollenberg MD, Muench G, et al. Anti-inflammatory benefits of antibiotics: Tylvalosin induces apoptosis of porcine neutrophils and macrophages, promotes Efferocytosis, and inhibits pro-inflammatory CXCL-8, IL1\u03b1, and LTB4 production, while inducing the release of pro-resolving Lipoxin A4 and Resolvin D1. Front Vet Sci. 2018;5:57.","journal-title":"Front Vet Sci"},{"issue":"1","key":"3571_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bcp.2014.04.015","volume":"90","author":"Z Zhao","year":"2014","unstructured":"Zhao Z, Tang X, Zhao X, Zhang M, Zhang W, Hou S, et al. Tylvalosin exhibits anti-inflammatory property and attenuates acute lung injury in different models possibly through suppression of NF-\u03baB activation. Biochem Pharmacol. 2014;90(1):73\u201387.","journal-title":"Biochem Pharmacol"},{"key":"3571_CR20","volume-title":"Successful control of PRRS utilizing oral fluid test in a farrow-to-nursery farm in Japan","author":"S Toda","year":"2020","unstructured":"Toda S, Ishizeki S, Watanabe Y, Kazuno Y, Ishikawa H. Successful control of PRRS utilizing oral fluid test in a farrow-to-nursery farm in Japan. Rio de Janeiro: International Pig Veterinary Society Congress; 2020."},{"issue":"9","key":"3571_CR21","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1128\/CVI.00517-09","volume":"17","author":"Y Liu","year":"2010","unstructured":"Liu Y, Shi W, Zhou E, Wang S, Hu S, Cai X, et al. Dynamic changes in inflammatory cytokines in pigs infected with highly pathogenic porcine reproductive and respiratory syndrome virus. Clin Vaccine Immunol. 2010;17(9):1439\u201345.","journal-title":"Clin Vaccine Immunol"},{"issue":"1\u20132","key":"3571_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vetmic.2012.09.013","volume":"163","author":"E Weesendorp","year":"2013","unstructured":"Weesendorp E, Morgan S, Stockhofe-Zurwieden N, Popma-De Graaf DJ, Graham SP, Rebel JM. Comparative analysis of immune responses following experimental infection of pigs with European porcine reproductive and respiratory syndrome virus strains of differing virulence. Vet Microbiol. 2013;163(1\u20132):1\u201312.","journal-title":"Vet Microbiol"},{"issue":"3\u20134","key":"3571_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.vetmic.2013.12.022","volume":"169","author":"D Han","year":"2014","unstructured":"Han D, Hu Y, Li L, Tian H, Chen Z, Wang L, et al. Highly pathogenic porcine reproductive and respiratory syndrome virus infection results in acute lung injury of the infected pigs. Vet Microbiol. 2014;169(3\u20134):135\u201346.","journal-title":"Vet Microbiol"},{"key":"3571_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-animal-022114-111025","volume":"4","author":"JK Lunney","year":"2016","unstructured":"Lunney JK, Fang Y, Ladinig A, Chen N, Li Y, Rowland B, et al. Porcine reproductive and respiratory syndrome virus (PRRSV): pathogenesis and interaction with the immune system. Annu Rev Anim Biosci. 2016;4:129\u201354.","journal-title":"Annu Rev Anim Biosci"},{"issue":"3","key":"3571_CR25","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.tvjl.2007.05.022","volume":"177","author":"E Mateu","year":"2008","unstructured":"Mateu E, Diaz I. The challenge of PRRS immunology. Vet J. 2008;177(3):345\u201351.","journal-title":"Vet J"},{"issue":"3","key":"3571_CR26","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.coviro.2012.02.002","volume":"2","author":"RJ Chand","year":"2012","unstructured":"Chand RJ, Trible BR, Rowland RR. Pathogenesis of porcine reproductive and respiratory syndrome virus. Curr Opin Virol. 2012;2(3):256\u201363.","journal-title":"Curr Opin Virol"},{"issue":"4","key":"3571_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1089\/vim.2009.0003","volume":"22","author":"J G\u00f3mez-Laguna","year":"2009","unstructured":"G\u00f3mez-Laguna J, Salguero F, De Marco M, Pallar\u00e9s F, Bernab\u00e9 A, Carrasco L. Changes in lymphocyte subsets and cytokines during European porcine reproductive and respiratory syndrome: increased expression of IL-12 and IL-10 and proliferation of CD4(\u2212)CD8(high). Viral Immunol. 2009;22(4):261\u201371.","journal-title":"Viral Immunol"},{"key":"3571_CR28","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3389\/fimmu.2018.00302","volume":"9","author":"P Zimmermann","year":"2018","unstructured":"Zimmermann P, Ziesenitz VC, Curtis N, Ritz N. The Immunomodulatory effects of macrolides\u2014a systematic review of the underlying mechanisms. Front Immunol. 2018;9:302.","journal-title":"Front Immunol"},{"issue":"2\u20133","key":"3571_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1053\/jcpa.2002.0566","volume":"127","author":"C Choi","year":"2002","unstructured":"Choi C, Cho WS, Kim B, Chae C. Expression of interferon-gamma and tumour necrosis factor-alpha in pigs experimentally infected with porcine reproductive and respiratory syndrome virus (PRRSV). J Comp Pathol. 2002;127(2\u20133):106\u201313.","journal-title":"J Comp Pathol"},{"issue":"3","key":"3571_CR30","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1006\/scdb.1998.0244","volume":"9","author":"P Krajcsi","year":"1998","unstructured":"Krajcsi P, Wold WS. Inhibition of tumor necrosis factor and interferon triggered responses by DNA viruses. Semin Cell Dev Biol. 1998;9(3):351\u20138.","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"3571_CR31","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1128\/JCM.41.3.960-966.2003","volume":"41","author":"S van Gucht","year":"2003","unstructured":"van Gucht S, van Reeth K, Pensaert M. Interaction between porcine reproductive-respiratory syndrome virus and bacterial endotoxin in the lungs of pigs: potentiation of cytokine production and respiratory disease. J Clin Microbiol. 2003;41(3):960\u20136.","journal-title":"J Clin Microbiol"},{"issue":"4\u20135","key":"3571_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1359-6101(02)00020-5","volume":"13","author":"WP Arend","year":"2002","unstructured":"Arend WP. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 2002;13(4\u20135):323\u201340.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"3571_CR33","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1128\/CVI.05490-11","volume":"19","author":"SL Brockmeier","year":"2012","unstructured":"Brockmeier SL, Loving CL, Nelson EA, Miller LC, Nicholson TL, Register KB, et al. The presence of alpha interferon at the time of infection alters the innate and adaptive immune responses to porcine reproductive and respiratory syndrome virus. Clin Vaccine Immunol. 2012;19(4):508\u201314.","journal-title":"Clin Vaccine Immunol"},{"issue":"1\u20132","key":"3571_CR34","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.virusres.2010.09.001","volume":"154","author":"RR Rowland","year":"2010","unstructured":"Rowland RR. The interaction between PRRSV and the late gestation pig fetus. Virus Res. 2010;154(1\u20132):114\u201322.","journal-title":"Virus Res"},{"issue":"3","key":"3571_CR35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1177\/104063879600800301","volume":"8","author":"KM Lager","year":"1996","unstructured":"Lager KM, Halbur PG. Gross and microscopic lesions in porcine fetuses infected with porcine reproductive and respiratory syndrome virus. J Vet Diagn Investig. 1996;8(3):275\u201382.","journal-title":"J Vet Diagn Investig"},{"issue":"1","key":"3571_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40813-021-00203-4","volume":"7","author":"D Torrents","year":"2021","unstructured":"Torrents D, Miranda J, Gauger PC, Ramirez A, Linhares D. Effect of PRRSV stability on productive parameters in breeding herds of a swine large integrated group in Spain. Porcine Health Manag. 2021;7(1):21.","journal-title":"Porcine Health Manag"},{"issue":"3","key":"3571_CR37","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1128\/JCM.37.3.620-627.1999","volume":"37","author":"EL Thacker","year":"1999","unstructured":"Thacker EL, Halbur PG, Ross RF, Thanawongnuwech R, Thacker BJ. Mycoplasma hyopneumoniae potentiation of porcine reproductive and respiratory syndrome virus-induced pneumonia. J Clin Microbiol. 1999;37(3):620\u20137.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"3571_CR38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.54846\/jshap\/913","volume":"24","author":"TL O\u2019Sullivan","year":"2016","unstructured":"O\u2019Sullivan TL, Johnson R, Poljak Z, Gu Y, DeLay J, Friendship RM. An experimental study with a vaccine strain of porcine reproductive and respiratory syndrome virus to determine effects on viremia assessed by reverse transcriptase-polymerase chain reaction in pigs fed rations medicated with tilmicosin or non-medicated. J Swine Health Prod. 2016;24(2):81\u201392.","journal-title":"J Swine Health Prod"},{"issue":"3","key":"3571_CR39","doi-asserted-by":"publisher","first-page":"e0151198","DOI":"10.1371\/journal.pone.0151198","volume":"11","author":"P Novakovic","year":"2016","unstructured":"Novakovic P, Harding JC, Al-Dissi AN, Ladinig A, Detmer SE. Pathologic evaluation of type 2 porcine reproductive and respiratory syndrome virus infection at the maternal-fetal Interface of late gestation pregnant gilts. PLoS One. 2016;11(3):e0151198.","journal-title":"PLoS One"},{"key":"3571_CR40","volume-title":"Guideline for the demonstration of efficacy for veterinary medicinal products containing antimicrobial substances. EMA\/CVMP\/627\/2001-Rev.1","author":"EM Agency","year":"2016","unstructured":"Agency EM. CVM Guidance for Industry #85 \/ VICH GL 9 Good Clinical Practice (GCP), CVMP Guideline for the demonstration of efficacy for veterinary medicinal products containing antimicrobial substances. EMA\/CVMP\/627\/2001-Rev.1. 2016."},{"issue":"1\u20132","key":"3571_CR41","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.vetmic.2013.02.029","volume":"165","author":"T Stadejek","year":"2013","unstructured":"Stadejek T, Stankevicius A, Murtaugh MP, Oleksiewicz MB. Molecular evolution of PRRSV in Europe: current state of play. Vet Microbiol. 2013;165(1\u20132):21\u20138.","journal-title":"Vet Microbiol"},{"issue":"4","key":"3571_CR42","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1042\/CS20050086","volume":"109","author":"S Bustin","year":"2005","unstructured":"Bustin S, Mueller R. Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis. Clin Sci (Lond). 2005;109(4):365\u201379.","journal-title":"Clin Sci (Lond)"},{"key":"3571_CR43","unstructured":"R-Core-Team. R: a language and environment for statistical computing. R Foundation for statistical computing. Vienna, Austria.2020. p. https:\/\/www.R-project.org\/."},{"key":"3571_CR44","doi-asserted-by":"crossref","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S. Fitting Linear Mixed-Effects Models Using lme4. https:\/\/wwwjstatsoftorg\/indexphp\/jss. 2015.","DOI":"10.18637\/jss.v067.i01"},{"key":"3571_CR45","unstructured":"Thernau T. A Package for Survival Analysis in R. R package version 3.1\u201312. 2020. p. https:\/\/CRAN.R-project.org\/package=survival."},{"key":"3571_CR46","unstructured":"Therneau T. coxme: Mixed Effects Cox Models. R package version 2.2\u201316. p. https:\/\/CRAN.R-project.org\/package=coxme."}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-023-03571-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-023-03571-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-023-03571-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T11:12:57Z","timestamp":1728817977000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-023-03571-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3571"],"URL":"https:\/\/doi.org\/10.1186\/s12917-023-03571-x","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"assertion":[{"value":"7 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"These studies were approved by the relevant clinical governance committees and were undertaken in compliance with local regulations, as appropriate. The PRRSV challenge study in pregnant sows was reviewed and approved by the RTI, LLC Institutional Animal Care and Use Committee. The piglet dual challenge study was conducted under The United Kingdom Home Office license under the Animals (Scientific Procedures) Act 1986.The studies meet ARRIVE requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors VLF, ALR and HB are employees of ECO Animal Health which manufactures Aivolosin\u00ae 62.5% Water Soluble Granules used as the water treatment in this study. MH is a consultant for ECO Animal Health.Moredun Scientific, RTI and the Roslin Institue are independent scientific research organisations. ECO Animal Health supplied the Aivlosin\u00ae used in these studies. This association did not in any way affect or influence the results of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}